Furthermore, although non-HDL-C levels tended to increase with higher BMI, this trend did not reach statistical significance.
← all excerpts
Obesity as a predictor of atherogenic dyslipidemia in patients with metabolic dysfunction associated steatotic liver disease.
1
—
—